Degarelix Versus Leuprolide in Patients With Prostate Cancer: Effect in Metastatic Patients As Assessed By Serum Alkaline Phosphatase

Schroder, F. H.; Tombal, Bertrand; Boccon-Gibod, L.; Miller, K.; Jensen, J. K.; Olesen, T. K.; Persson, B-E

doi:10.1016/S1569-9056(09)60048-8

Degarelix Versus Leuprolide in Patients With Prostate Cancer: Effect in Metastatic Patients As Assessed By Serum Alkaline Phosphatase

Schroder, F. H.

;

Tombal, Bertrand

;

Boccon-Gibod, L.

;

Miller, K.

;

Persson, B-E

;et.al.

(2009)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
510.27 KB

Request a copy

Details

Authors

Schroder, F. H.
Author
Tombal, BertrandUCLouvain
Author
Boccon-Gibod, L.
Author
Miller, K.
Author
Persson, B-E
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/FSIO - Département de physiologie et pharmacologie

Citations

APA
Chicago
FWB

Schroder, F. H., Tombal, B., Boccon-Gibod, L., Miller, K., Jensen, J. K., Olesen, T. K., & Persson, B.-E. (2009). Degarelix Versus Leuprolide in Patients With Prostate Cancer: Effect in Metastatic Patients As Assessed By Serum Alkaline Phosphatase. European Urology Supplements, 8(4), 130. https://doi.org/10.1016/S1569-9056(09)60048-8 (Original work published 2009)